抗腫瘍免疫療法増強剤

Japanese Patent JP7365694

B2

The disclosure provides a composition for inhibiting the growth and/or invasion of tumor cells, an enhancer of an anti-tumor effect of a drug for the purpose of removing immunosuppression caused by cancer, or the like, which is characterized by being used for a specific subject.

WO/2002/016615	CRYSTAL STRUCTURE OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE AND ARGININE DEIMINASE
JP2009516671	Treatment of neuroendocrine tumors with mTOR inhibitors
JP2017505763	Biological materials and their therapeutic uses

Nobuo Tsukamoto
Yutaka Kawakami

JP2019527085A

October 20, 2023

June 29, 2018

Click for automatic bibliography generation  

Nobuo Tsukamoto

A61K45/00; A61K31/136; A61K31/405; A61K31/506; A61K39/395; A61K45/06; A61P35/00; A61P43/00; C07K16/40; C12N9/99; C12Q1/68; G01N33/15

JP2012533619A

Cancer Treatment Reviews,2010年,36,pp.492-500
Blood,2010年,115(17),pp.3520-3530
BELGUISE K.et al.,Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor,Slug,and invasivephenotype.,Cancer Res.,2007年12月15日,67(24),pp.11742-11750
Cancer Immnol Res.,2017年02月,5(2),pp.157-169
Nature Immunology,2011年,12(9),pp.870-878
Med. Chem. Commun.,2017年05月16日,8,pp.1378-1392

Shinichiro Tanaka
▲吉▼田 和彦
Hiroyuki Suda
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Masaru Shimura

Previous Patent: Systems and methods for improved sustainability of high-performance FRC using multiscale capture-typ...

Next Patent: Magnet structure containing multiple unit magnets in the form of blocks